GSTO1 and nonpapillary renal cell carcinoma: Furthermore, we evaluated GSTO1-1 and GSTO2-2 expression in ccRCC and adjacent non-tumor tissue, as well as phosphorylation status of two important survival pathways, PI3K/Akt/mTOR and Raf/MEK/ERK.